financetom
Business
financetom
/
Business
/
Protagonist Therapeutics Insider Sold Shares Worth $2,520,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Protagonist Therapeutics Insider Sold Shares Worth $2,520,000, According to a Recent SEC Filing
Mar 30, 2026 1:07 AM

03:38 AM EDT, 03/30/2026 (MT Newswires) -- Harold E Selick, Director, on March 26, 2026, sold 24,000 shares in Protagonist Therapeutics ( PTGX ) for $2,520,000. Following the Form 4 filing with the SEC, Selick has control over a total of 60,845 common shares of the company, with 60,845 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1377121/000110465926036318/xslF345X05/tm2610129-2_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Indonesia aiming to increase state ownership of Freeport Indonesia by more than 10%, minister says
Indonesia aiming to increase state ownership of Freeport Indonesia by more than 10%, minister says
Sep 15, 2025
JAKARTA, Sept 15 (Reuters) - The Indonesian government is aiming to increase the state share of the copper and gold miner PT Freeport Indonesia by more than 10%, the country's mining minister Bahlil Lahadalia said on Monday. Indonesia has flagged its interest in gaining more control over Freeport Indonesia in recent years, with Bahlil saying that it would be a...
Nvidia Violated Anti-Monopoly Law, Chinese Market Regulator Says; Shares Down Pre-Bell
Nvidia Violated Anti-Monopoly Law, Chinese Market Regulator Says; Shares Down Pre-Bell
Sep 15, 2025
05:35 AM EDT, 09/15/2025 (MT Newswires) -- Nvidia ( NVDA ) has violated China's anti-monopoly law, the country's market regulator said Monday, following a preliminary probe. According to the State Administration for Market Regulation, Nvidia ( NVDA ) was suspected of violations in relation to its acquisition of Israel's Mellanox Technologies. The regulator did not disclose additional details of the...
ATIS Acquires Technical Inspection Agency USA (TIA USA)
ATIS Acquires Technical Inspection Agency USA (TIA USA)
Sep 15, 2025
ST. LOUIS, Sept. 15, 2025 (GLOBE NEWSWIRE) -- ATIS, a premier provider of elevator and escalator safety inspections, consulting, and managed services, is pleased to announce the acquisition of Technical Inspection Agency USA (TIA USA). TIA USA is a respected provider of comprehensive inspections, consulting, and maintenance management services for vertical transportation systems, headquartered in Las Vegas, NV and supporting...
Update: Market Chatter: Kenvue CEO Sough to Prevent RFK Jr. From Citing Tylenol as Potential Autism Cause
Update: Market Chatter: Kenvue CEO Sough to Prevent RFK Jr. From Citing Tylenol as Potential Autism Cause
Sep 15, 2025
05:35 AM EDT, 09/15/2025 (MT Newswires) -- (Updates with response from the Department of Health and Human Services in the fifth and sixth paragraphs) Kenvue's ( KVUE ) interim chief executive Kirk Perry had a private meeting with Robert F Kennedy Jr. to dissuade the Secretary of Health and Human Services from citing Tylenol as a potential cause for autism,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved